
Insulin Delivery Options for the Tech Averse with Dr. David Soliman
12/12/23 • 21 min
Previous Episode

Practical Considerations to Help Patients with Type 2 Diabetes Start and Stay on Non-Insulin Injectable Therapies
Debbie Hinnen APN, BC-ADM, CDCES, FAAN joins The Huddle to share her expertise and experiences starting patients with type 2 diabetes on injectable, non-insulin therapies. We will cover topics like how to have a conversation with someone who may have concerns about starting a patient on an injectable, setting realistic expectations, storage and side effects.
Disclosures: Speaker/Consultant for Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, Intuity
This podcast was developed in partnership with Eli Lilly and Company.
Resources:
Download a patient-focused tipsheet that complements the topics covered in this podcast. https://www.adces.org/docs/default-source/handouts/cvd/60-23_tipsheet-startstaynoninsulininjectable-9.pdf?sfvrsn=7f11759_5
1. https://pi.lilly.com/us/trulicity-uspi.pdf
2. https://www.bydureon.com/bydureon-bcise.html
3. https://www.novo-pi.com/victoza.pdf
4. https://www.novo-pi.com/ozempic.pdf
5. https://www.novo-pi.com/rybelsus.pdf
6. https://pi.lilly.com/us/mounjaro-uspi.pdf?s=pi
7. Triplitt & Solis-Herrera. The Diabetes Educator. 2015;41:S22
8. De Block et al., DOM. 2023;25:3
9. Frias et al., Lancet Diabetes Endocrinol. 2021;9:563
10. Jendle et al., Diabetes Metab Res Rev. 2016;32:776
11. El Sayed et al., Diabetes Care. 2023;46:S140
Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.
Learn more about ADCES and the many benefits of membership at adces.org/join.
Next Episode

Revisiting T1D: Dispelling Myths & Highlighting the Importance of Screening with Anastasia Albanese-O’Neill
Understanding the ins and outs of Type 1 diabetes and its stages is key in accurately screening for and managing the disease. In the first of a three-part series, we're joined by Anastasia Albanese-O’Neill, PhD, APRN, CDCES. In this episode, Dr. O'Neill talks about common misconceptions of T1D, as well as the stages of T1D and the importance of evaluating and understanding these stages when diagnosing and working with people and families affected by T1D.
Educational grant support for this episode is provided by Sanofi.
View our guide covering some of the ins and outs of screening, educational grant support provided by Sanofi: T1D Screening (adces.org)
Tune into our other podcasts in this T1D screening series:
Learn more about increasing access to screening: https://thehuddle.simplecast.com/episodes/communities-increasing-access-t1d-screening
Learn more about psychosocial considerations with screening: https://thehuddle.simplecast.com/episodes/psychosocial-considerations-t1d-screening
Learn more about T1D risk screening and additional resources on Breakthrough T1D's website: Type 1 Diabetes - Breakthrough T1D
Learn more and gain access to T1D screening kits via TrialNet: https://www.trialnet.org/ or ASK: https://www.askhealth.org/?_ga=2.144097589.1682361371.1702935724-1205645336.1702935724
Learn more about the Search for Diabetes in Youth study here: SEARCH FOR DIABETES IN YOUTH
Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.
Learn more about ADCES and the many benefits of membership at adces.org/join.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-huddle-conversations-with-the-diabetes-care-team-48199/insulin-delivery-options-for-the-tech-averse-with-dr-david-soliman-39271741"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to insulin delivery options for the tech averse with dr. david soliman on goodpods" style="width: 225px" /> </a>
Copy